Latest Oral Drug Treatment for Ulcerative Colitis

Article

A study that assessed novel drug delivery methods has shown that curcumin-loaded pH-sensitive microparticles may be an efficient and effective approach to treating ulcerative colitis (UC).

A study that assessed novel drug delivery methods has shown that curcumin-loaded pH-sensitive microparticles may be an efficient and effective approach to treating ulcerative colitis (UC).

Results from the study, led by researchers from the Institute for Biomedical Sciences at Georgia State University and Southwest University in China, were recently published in the journal Colloids and Surfaces B: Biointerfaces.

The researchers used an emulsion-solvent evaporation method to fabricate pH-sensitive microparticles and noted curcumin could weaken inflammation in colitis-stricken animals thereby reducing UC relapse rate in animals during pre-clinical experiments.

Although altering many factors eventually led to determining the most effective makeup for the microparticles, the researchers noted there is still a huge gap in capable carrier systems of targeted UC therapy.

Didier Merlin, professor in the Institute for Biomedical Sciences at Georgia State said, “Orally administered microparticles may offer an efficient drug delivery system because they are characterized by a high drug loading capacity and may target colitis tissues based on abnormalities.”

Related Videos
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Ali Rezaie, MD | Credit: X
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Paul Feuerstadt, MD | Yale School of Medicine
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
| Image Credit: LinkedIn
Oriana Damas, MD | Credit University of Miami
© 2024 MJH Life Sciences

All rights reserved.